BIIB
Biogen Appoints Tim Power as Head of Investor Relations
Monday, December 9, 2024 BiopharmaWatch Research 1 min read Key Takeaway: Biogen Appoints Tim Power as Head of Investor Relations
Price reaction · baseline $157.78 (2024-12-06 close) · clean, no other BIIB news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis
Full Press Release Details
Biogen Appoints Tim Power as Head of Investor Relations.